Scenarios that move DTIL

Precision BioSciences, Inc. - Common Stock

Scenarios that move DTIL: 1 analysis, 0 positive, 1 negative.

  1. · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▼ · impact -18 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing